Ticker Details
Oragenics Inc. Oragenics Inc is a biopharmaceutical company which engages in the discovery, development and commercialization of technologies associated with oral health, broad spectrum antibiotics and other general health benefits.
IPO Date:	March 1, 2004
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$2.37M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.09 | 6.25%
Avg Daily Range (30 D):	$0.02 | 2.83%
Avg Daily Range (90 D):	$0.02 | 3.43%

Institutional Daily Volume
Avg Daily Volume:	1.64M
Avg Daily Volume (30 D):	.02M
Avg Daily Volume (90 D):	.04M

Trade Size
Avg Trade Size (Sh.):	592
Avg Trade Size (Sh.) (30 D):	250
Avg Trade Size (Sh.) (90 D):	280

Institutional Trades
Total Institutional Trades:	14
Avg Institutional Trade:	$.83M
Avg Institutional Trade (30 D):	$M
Avg Institutional Trade (90 D):	$M
Avg Institutional Trade Volume:	M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$.67M
Avg Closing Trade (30 D):	$M
Avg Closing Trade (90 D):	$M
Avg Closing Volume:	.38K

News

Apr 9, 2025 @ 12:58 PM Oragenics, Inc. Announces Health and Disability Et... Source: N/A

Aug 16, 2024 @ 8:30 PM Oragenics, Inc. Provides Update on its Drug Intend... Source: Oragenics, Inc.

Jul 22, 2024 @ 8:58 PM Oragenics delays 2023 Annual Meeting - Investing.c... Source: Natashya Angelica

Jun 27, 2024 @ 12:30 PM Oragenics Develops Automated Intranasal Device for... Source: Oragenics

Jun 26, 2024 @ 8:47 PM Oragenics, Inc. Announces Closing of Public Offeri... Source: Oragenics

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-2.44	$-.57	$-.51
Diluted EPS	$-2.44	$-.57	$-.51
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-10.08M	$-2.53M	$-2.2M
Operating Income / Loss	$-10.47M	$-2.59M	$-2.26M
Cost of Revenue
Net Cash Flow	$M	$M	$M
PE Ratio

Splits
Jun 03, 2025	1:30
Jan 23, 2023	1:60
Jan 22, 2018	1:10
Sep 28, 2010	1:20